patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: OT: patientman..apparently, we will be doing some more waiting lol

 

For most, sorry for the OT comment.

EDIG is in decent shape, great shape from where they have come from.  Note the most recent PRs and record revs for this fiscal year, ending 3/31/08.  That's great, but they have a long way to go as well.  I own a shipload of EDIG and I beleive that stock has good potential to be a $1 without IP license deals just by becoming profitable in late 2008 with sales of their eVU product.  That's the major difference between EDIG and PTSC.   However, I'm still buying PTSC as that one should pay off much sooner, IMO.

The above comments are only the opine of one Big Dumb Guy from Tennessee.  For anyone not in either EDIG or PTSC, do a lot of DD before you buy.  Both are speculative penny stocks and both have great risks associated.  

To everyone, have a very Merry Christmas and remember to count your blessings as we head into 2008 -- even if your cousin's kid makes a mess on your newly cleaned carpets in your new house!

What was that saying about visiting family and fish...

John

 

Share
New Message
Please login to post a reply